Literature DB >> 6098367

Acute cerebellar toxicity after high-dose cytarabine associated with CNS accumulation of its metabolite, uracil arabinoside.

J A Lopez, R P Agarwal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6098367

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  7 in total

Review 1.  Cerebellar toxicity during cytarabine therapy associated with renal insufficiency.

Authors:  H Hasle
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  The toxicity of cytarabine.

Authors:  J Stentoft
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

3.  Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice.

Authors:  Jan H Beumer; Julie L Eiseman; Robert A Parise; Jeffry A Florian; Erin Joseph; David Z D'Argenio; Robert S Parker; Brittany Kay; Joseph M Covey; Merrill J Egorin
Journal:  Cancer Chemother Pharmacol       Date:  2007-11-15       Impact factor: 3.333

4.  Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin.

Authors:  J H Marsh; W Kreis; B Barile; S Akerman; P Schulman; S L Allen; L C DeMarco; M W Schuster; D R Budman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Exchange of cerebrospinal fluid in accidental intrathecal overdose of cytarabine.

Authors:  P Lafolie; J Liliemark; O Björk; J Aman; L Wranne; C Peterson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

6.  AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity.

Authors:  L H Lindner; H Ostermann; W Hiddemann; A Kiani; M Würfel; T Illmer; C Karsch; U Platzbecker; G Ehninger; E Schleyer
Journal:  Int J Hematol       Date:  2008-10-04       Impact factor: 2.490

Review 7.  Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action.

Authors:  Ellen J B Derissen; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2020-12       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.